The Placebo Effect: Is Awareness Impacting Efficacy?

  • Thread starter Thread starter Dadface
  • Start date Start date
AI Thread Summary
Volunteers in drug trials are typically informed about the possibility of receiving a placebo, which raises questions about the impact of this awareness on the placebo effect's efficacy. A reduced placebo effect could benefit trial outcomes by making it easier to distinguish the effects of the treatment from those of the placebo. However, this reduction would apply equally to both the placebo and treatment groups, thus not affecting the overall inference drawn from the trial data. Ethical considerations often dictate that placebos are not used in trials for conditions with existing treatments, as new drugs are usually compared to these existing therapies rather than a placebo.
Dadface
Messages
2,489
Reaction score
105
I am assuming that volunteers who take part in drug trial testing are aware of the fact that they may be given placebos.Is it likely that this awareness may make the placebo effect less efficacious? :confused:
 
Biology news on Phys.org
In a clinical trial, a decrease in the placebo effect would be an advantage for the advocates of the treatment. If you are the group conducting the trial, you want to see the clearest difference possible between the placebo and the treatment. The placebo effect refers to the tendency of people receiving a placebo to report amelioration of symptoms. This makes it more difficult to distinguish the difference between the placebo arm of the trial and the treatment arm of the trial.

If awareness of the possibility that a patient is receiving a placebo decreases the placebo effect, it will be easier to tell whether the drug is working or not when comparing data from the two trial arms.
 
Last edited:
Dadface said:
I am assuming that volunteers who take part in drug trial testing are aware of the fact that they may be given placebos.Is it likely that this awareness may make the placebo effect less efficacious? :confused:

Interesting, but this effect would be equal in both populations (placebo and drug). So it would not affect any inference you would draw.
 
Indeed, if the placebo effect were reduced, that would be a benefit in testing a novel drug since it too would have a reduced chance of getting a response due to placebo effect only.

In answer to the implied question, yes, if placebos are used, patients in the trial will be informed that this is a possibility. Although, unless something being tested is a novel drug for a condition that was previously untreatable, due to ethical considerations, usually placebos are not used for the control group. Instead, new drugs are usually compared against the existing treatments, and need to perform better than those rather than just better than nothing.
 
:approve:Interesting stuff.Thank you everyone for your answers.
 
https://www.nhs.uk/mental-health/conditions/body-dysmorphia/ Most people have some mild apprehension about their body, such as one thinks their nose is too big, hair too straight or curvy. At the extreme, cases such as this, are difficult to completely understand. https://www.msn.com/en-ca/health/other/why-would-someone-want-to-amputate-healthy-limbs/ar-AA1MrQK7?ocid=msedgntp&cvid=68ce4014b1fe4953b0b4bd22ef471ab9&ei=78 they feel like they're an amputee in the body of a regular person "For...
Thread 'Did they discover another descendant of homo erectus?'
The study provides critical new insights into the African Humid Period, a time between 14,500 and 5,000 years ago when the Sahara desert was a green savanna, rich in water bodies that facilitated human habitation and the spread of pastoralism. Later aridification turned this region into the world's largest desert. Due to the extreme aridity of the region today, DNA preservation is poor, making this pioneering ancient DNA study all the more significant. Genomic analyses reveal that the...
Popular article referring to the BA.2 variant: Popular article: (many words, little data) https://www.cnn.com/2022/02/17/health/ba-2-covid-severity/index.html Preprint article referring to the BA.2 variant: Preprint article: (At 52 pages, too many words!) https://www.biorxiv.org/content/10.1101/2022.02.14.480335v1.full.pdf [edited 1hr. after posting: Added preprint Abstract] Cheers, Tom
Back
Top